MarketResearchNest.com adds “Global Epigenetics Market 2017-2021” new report to its research database. The report spread across in 78 pages with tables and figures in it.
The research analysts forecast the global epigenetics market to grow at a CAGR of 13.22% during the period 2017-2021. Epigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops.
Get Report Details at https://www.marketresearchnest.com/global-epigenetics-market-2017-2021.html
The publisher recognizes the following companies as the key players in the global epigenetics market: Abcam, Bio-Rad Laboratories, Merck, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Active Motif, BellBrook Labs, BioVision, CELGENE, Cisbio.com, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.
One trend in the market is increasing demand for personalized medicine. The demand for personalized medicine is increasing and is expected to grow in future with a CAGR of more than 10%. The development of whole genome technology, companion diagnostics, and the growing number of retail clinics are some reasons for its growth.
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=253235 . (This is premium report, Single User License – USD 3500 and Multi User License – USD 4000)
According to the report, one driver in the market is increasing prevalence of cancer. Epigenetic mechanisms are essential for the normal development and maintenance of tissue-specific gene expression patterns in mammals. The disruption of epigenetic processes can lead to the malicious transformation of cells and altered gene function. Alteration in the heritable epigenetic marks can result in inappropriate activation or inhibition of various signaling pathways and lead to disease states such as cancer. Cancer is one of the major public health problems globally. It is one of the leading causes of death. It was estimated that in 2012, more than 2% new cancer cases occurred globally.
Further, the report states that one challenge in the market is difficulty in finding predictive epigenetic biomarker. A biomarker is a characteristic that is accurately measured and evaluated as an indicator of normal biological processes, pharmacologic responses, or pathogenic processes to a therapeutic intervention. It is any structure, substance, or method that can be measured in the body. It can be a product such as protein after gene expression, which can predict the incidence or outcome of a disease. The use of biomarkers in clinical and basic research as well as in clinical practice has become so ordinary that their presence as primary endpoints in clinical trials is now accepted almost without question.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Inquire before buying at https://www.marketresearchnest.com/enquirybuy.php?reportid=253235 . (This is premium report, Single User License – USD 3500 and Multi User License – USD 4000)
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.
Mr. Jeet Jain